Results 181 to 190 of about 10,318 (317)

Beyond Glycemic Control: GLP-1RA-Based Therapies and Emerging Targets Beyond the Metabolic Axis. [PDF]

J Clin Med
Matuszewski W, Wołos-Kłosowicz K, Włodarczyk P, Waśniewska P, Modzelewski R, Górny JM, Szklarz M, Madeksza M, Juranek J.   +8 more
europepmc   +1 more source

Randomised trial comparing weight loss through lifestyle and GLP-1 receptor agonist therapy in people with MASLD [PDF]

Background and Aims Glucagon-like peptide 1 receptor agonist (GLP-1RA) therapies deliver histological benefit in people with metabolic dysfunction-associated steatotic liver disease (MASLD).
Cobbold, Jeremy F, Cornfield, Thomas, Dong, Jiawen, Hodson, Leanne, Moolla, Ahmad, Mouchti, Sofia, Mózes, Ferenc E, Neubauer, Stefan, Othonos, Nantia, Poolman, Toryn, Ray, David W, Smith, Kieran, Thomaides-Brears, Helena, Tomlinson, Jeremy W, White, Sarah   +14 more
core  

Variation in uptake of sodium glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor analogues in adults with type 2 diabetes at high cardiovascular risk

Purpose: We quantified variation in the uptake of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor analogues (GLP-1RA) across sociodemographic, behavioural and clinical characteristics of people with type 2 ...
Day, RO , de Oliveira Costa, J , Falster, MO , Gibson, AA, Greenfield, JR , Havard, A, Lin, J , Milder, TY, Morton, JI, Neuen, BL, Pearson, SA , Sacre, JW   +11 more
core   +1 more source

Promising results but caution needed in GLP-1RA large scale epidemiology

Salil V. Deo, Salil V. Deo
openalex   +1 more source

Efficacy of Modern Diabetes Treatments- Dpp-4i, Sglt-2i, Glp-1ra- in White and Asian Patients With Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

, 2020
Sushrima Gan, Adem Y. Dawed, Louise A. Donnelly, ATN Nair, Colin NA Palmer, Viswanathan Mohan, Ewan R. Pearson   +6 more
openalex   +1 more source

Trends in First-Line Glucose-Lowering Drug Use in Adults With Type 2 Diabetes in Light of Emerging Evidence for SGLT-2i and GLP-1RA

, 2021
Ho‐Jin Shin, Sebastian Schneeweiß, Robert J. Glynn, Elisabetta Patorno   +3 more
openalex   +1 more source

Response to Comment on Gan et al. Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care 2020;43:1948–1957 [PDF]

, 2020
Sushrima Gan, Adem Y. Dawed, Louise A. Donnelly, Anand Thakarakkattil Narayanan Nair, Colin N.A. Palmer, Viswanathan Mohan, Ewan R. Pearson   +6 more
openalex   +1 more source

GLP-1RAs in patients with psoriasis

Hormones
Ioanna A. Paschou, Evangelia Sali, Stavroula A. Paschou, Theodora Psaltopoulou, Electra Nicolaidou, Alexander J. Stratigos   +5 more
openaire   +3 more sources

Nutrition Strategies for Next‐Generation Incretin Therapies: A Systematic Scoping Review of the Current Evidence

Obesity Reviews, Volume 27, Issue 6, June 2026.
ABSTRACT Next‐generation incretin therapies, including semaglutide and tirzepatide, have transformed obesity and Type 2 diabetes management. However, evidence‐based nutritional strategies to support safe and effective use of these agents remain limited.
Marie Spreckley, Cara F. Ruggiero, Adrian Brown   +2 more
wiley   +1 more source

Underlying mechanisms and cardioprotective effects of SGLT2i and GLP-1Ra: insights from cardiovascular magnetic resonance [PDF]

Angelica Cersosimo, Nadia Salerno, Jolanda Sabatino, Alessandra Scatteia, Giandomenico Bisaccia, Salvatore De Rosa, Santo Dellegrottaglie, Chiara Bucciarelli‐Ducci, Daniele Torella, Isabella Leo   +9 more
openalex   +1 more source